Shin et al. demonstrated that hypermethylation of RUNX3 was associated with an unfavorable prognosis in a small CRC cohort comprising 62 patients, indicating an inactivated form because of transcriptional silencing [40]. This evidence concerns the gene RUNX3 and colorectal carcinoma.